Across the globe, obesity persists as a formidable public health challenge, reflecting a rise in metabolic disorders closely associated with modern diets and sedentary lifestyles. While traditional strategies like diet modification and exercise have been primary focus areas, recent scientific
In the ongoing battle against child abuse, radiologists have emerged as pivotal figures, wielding advanced diagnostic imaging techniques to identify and prevent harm. This role gained attention at the European Congress of Radiology, where Dr. Rick R. Van Rijn of Amsterdam University Medical Center
Ivan Kairatov is a highly respected biopharma expert who has made significant contributions to the understanding and innovation in cancer research. With a focus on neuroblastoma, a particularly aggressive childhood cancer, his work is paving the way for new treatment strategies. In this interview,
The laboratory automation market stands poised on the brink of a transformative decade, projected to surge in value, reaching an anticipated $12.5 billion by 2032. This robust growth trajectory, characterized by a noteworthy compound annual growth rate (CAGR) of 8.18%, is powered by an amalgamation
Ivan Kairatov's expertise in biopharma, particularly in advancing technologies and innovation within the industry, positions him as a leading figure in the field of biomedical imaging. With a wealth of experience in research and development, Ivan's contributions have greatly impacted the realm of
In recent times, Sanofi's Sarclisa (isatuximab) has emerged as a promising advancement in the treatment of multiple myeloma (MM), a type of blood cancer. Approximately 46,000 new cases are diagnosed annually in Europe alone, making MM the second most prevalent blood cancer after non-Hodgkin
As the biopharmaceutical sector traverses the complex terrain of 2025, it encounters a multitude of challenges shaped by financial constraints, regulatory shifts, and evolving geopolitical dynamics. The industry is marked by notable changes detailed in Ernst & Young LLP's (EY) annual Biotech Beyond
Could an individual's genetic information hold the keys to personalized treatment for mood disorders like major depressive disorder and bipolar disorder? Advances in genetic research suggest this might soon be possible, offering the potential to revolutionize psychiatric care. By understanding a
The ongoing quest to treat mitochondrial diseases has achieved a revolutionary stride, enhancing possibilities within gene therapy landscapes through mitochondrial base editing (mtBE). Recent innovations by scientists at the University Medical Center Utrecht signify a substantial advancement in
How can artificial intelligence transform your doctor’s visit without stepping into the clinic? Remote medical consultations, commonly referred to as eVisits, have surged in popularity within the past few years. A fascinating study revealed that nearly 70% of patients now prefer virtual
